Lactococcus lactis KF140 Ameliorates Nonalcoholic Fatty Liver Disease Induced by N ε ‐Carboxymethyl‐Lysine and High‐Fat Diet
Molecular Nutrition & Food Research · 2024
DOI: 10.1002/mnfr.202400260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Hye-Bin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Food Functionality Research Division, Korea Food Research Institute, Jeollabuk-do, 55365, Republic of Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Lysine, Lactococcus lactis, Diet, High-Fat. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: INNOPOLIS Foundation, Korea Food Research Institute.
Abstract (Originalsprache)
Scope Long‐term consumption of excessive dietary advanced glycation end‐products such as N ε ‐carboxymethyl‐lysine (CML), which are produced by the Maillard reaction during food thermal processing, leads to nonalcoholic fatty liver disease (NAFLD) along with high fat consumption. The study previously finds that administration of Lactococcus lactis KF140 (LL‐KF140) detoxifies CML by decreasing CML absorption both in a rat model and clinical trial. Methods and results The present study evaluates the ameliorative effect of LL‐KF140 on NAFLD and fatty liver‐related biomarkers in a mouse model induced by CML and high fat. LL‐KF140 is orally administered to mice at a concentration of 1 × 10 7 or 1 × 10 8 colony‐forming unit (CFU) per mouse for 8 weeks. LL‐KF140 administration ameliorates the NAFLD‐related symptoms by reducing body weight and fat mass gain along with levels of serum aspartate transaminase, alanine transferase, and lipids as well as glucose intolerance and insulin resistance in CML‐treated mice. In addition, histological analysis including staining and western blotting shows that LL‐KF140 suppresses the lipogenesis pathway and CML absorption, thereby suppressing CML‐induced NAFLD. Conclusion These findings suggest that LL‐KF140 attenuates dietary CML‐induced NAFLD by suppressing the de novo lipogenesis pathway, and it may be used as a probiotic strain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food Functionality Research Division, Korea Food Research Institute, Jeollabuk-do, 55365, Republic of Korea.
- Department of Biotechnology, Korea University, Seoul, 02841, Republic of Korea.
- Department of Food Biotechnology, Korea National University of Science and Technology, Daejeon, 34113, Republic of Korea.
ORCID-Profile: Sang Keun Ha, Ho-Young Park
Förderung
- INNOPOLIS Foundation
- Korea Food Research Institute
Zitieren
APA
Lee, H. B., Park, M., Lee, S. Y., Ha, S. K., Kim, Y., Lee, K. W., & Park, H. Y. (2024). Lactococcus lactis KF140 Ameliorates Nonalcoholic Fatty Liver Disease Induced by N ε ‐Carboxymethyl‐Lysine and High‐Fat Diet. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202400260
Vancouver
Lee HB, Park M, Lee SY, Ha SK, Kim Y, Lee KW, et al. Lactococcus lactis KF140 Ameliorates Nonalcoholic Fatty Liver Disease Induced by N ε ‐Carboxymethyl‐Lysine and High‐Fat Diet. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202400260
BibTeX
@article{Lee2024,
author = {Lee, Hye-Bin and Park, Miri and Lee, So-Young and Ha, Sang Keun and Kim, Yoonsook and Lee, Kwang-Won and Park, Ho-Young},
title = {Lactococcus lactis KF140 Ameliorates Nonalcoholic Fatty Liver Disease Induced by N ε ‐Carboxymethyl‐Lysine and High‐Fat Diet},
journal = {Molecular Nutrition & Food Research},
year = {2024},
doi = {10.1002/mnfr.202400260}
}
EUVIMED